Search Results 1081-1090 of 38035 for Two-phase

1. Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) - Mayo Clinic

   Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

2. A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

3. Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

4. Skin Cancer Clinical Trials - Mayo Clinic Research

   Phase 1b of the study will evaluate the safety of talimogene laherparepvec in combination with ipilimumab. Phase 2 is a randomized study that will evaluate ...

5. Alzheimer's Disease Clinical Trials - Mayo Clinic Research

   The purpose of this study is to provide subjects who have completed participation in a Phase 2 or Phase 3 trial with TRx0237 continued access to therapy and to ...

6. ALTTO Test of Dual HER2 Blockade Finds Single Agent - Trastuzumab - Remains Gold Standard - Mayo Clinic News Network

   Results of the phase III clinical trial, ALTTO (Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization study), demonstrated that adding lapatinib to ...

7. A Study to Compare the Ability of Identifying Uric Acid Crystals between Two CT Scanning Techniques - Mayo Clinic

   Study phase. 0. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

8. SUPRAME-ACTengine® IMA203 Vs. Investigator's Choice Of Treatment In Previously Treated, Unresectable Or Metastatic Cutaneous Melanoma - Mayo Clinic

   Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

9. Publications - David J. Sas, D.O. - Mayo Clinic

   ... phase 2 study (PHYOX8). Pediatr Nephrol. 2025 Jun; 40 (6):1939-1948 Epub 2025 Jan 28. View PubMed; Michael M, Harvey E, Milliner DS, Frishberg Y, Sas DJ ...

10. Stress and hair loss: Are they related? - Mayo Clinic

    Telogen effluvium. In telogen effluvium (TEL-o-jun uh-FLOO-vee-um), significant stress pushes large numbers of hair follicles into a resting phase.